Discover our medicines
Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
Explore our science
Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
Learn about our impact
Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.
幸运飞行艇168查询体彩赛事记录网_历史号码查询|全国168飞艇官网开奖结果记录数据 Novartis Financial Results – Q3 2025
Novartis announces the company’s financial results for the third quarter of 2025.
Manufacturing expansion in the United States
Novartis is expanding our manufacturing and R&D facilities in the US to scale innovation, help patients and create jobs.
168体彩幸运飞行艇官方网_全国统一结果直播体彩网 ｜飞行艇全国历史记录直播体彩 Latest news
Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline
Live. Magazine
Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company.
Novartis in Society Integrated Report 2024
Read more about our performance against our business, environmental, social and governance (ESG) priorities in the Novartis in Society Integrated Report 2024.